According to Medpace's latest financial reports the company's current EPS (TTM) is $8.85. In 2022 the company made an earnings per share (EPS) of $7.60 an increase over its 2021 EPS that were of $5.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $8.85 | 16.45% |
2022 | $7.60 | 50.2% |
2021 | $5.06 | 24.32% |
2020 | $4.07 | 45.88% |
2019 | $2.79 | 36.1% |
2018 | $2.05 | 105% |
2017 | $1.00 | 184.37% |
2016 | $0.35 | -260.69% |
2015 | -$0.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -124.63% | ๐บ๐ธ USA |